James E. Flynn - Sep 12, 2025 SCHEDULE 13G Report for BioCryst Pharmaceuticals, Inc. Common Stock (BCRX)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Mgmt, L.P.
Security
BioCryst Pharmaceuticals, Inc. Common Stock
Symbol
BCRX
Shares outstanding
210M shares
Disclosed Ownership
12.2M shares
Ownership
5.8%
Form type
SCHEDULE 13G
Date filed
9/19/2025, 12:23 PM
Date of event
Sep 12, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 5.8% 12.2M 0 12.2M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 5.8% 12.2M 0 12.2M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 5.8% 12.2M 0 12.2M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 5.8% 12.2M 0 12.2M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact